What information and decision-making processes determine how and whether an experimental medical technology becomes accepted and used? Adopting New Medical Technology reviews the strengths and weaknesses of present coverage and adoption practices, highlights opportunities for improving both the decision-making processes and the underlying information base, and considers approaches to instituting a much-needed increase in financial support for evaluative research. Essays explore the nature of technological change; the use of technology assessment in decisions by health care providers and federal, for-profit, and not-for-profit payers; the role of the courts in determining benefits coverage; strengthening the connections between evaluative research and coverage decision-making; manufacturers' responses to the increased demand for outcomes research; and the implications of health care reform for technology policy.

New medical technologies--pharmaceuticals, medical devices, and procedures--often allow great improvements in the outcomes of medical care, but they are also widely believed to be a major cause of increasing costs. Selective adoption of new technologies is crucial in the quest to control health care costs while preserving or enhancing the quality of care. This report focuses on evaluation and adoption of innovative procedures and medical devices by managed care organizations (MCOs). The project had two primary objectives: (1) to understand current MCO processes for making coverage, medical-necessity, and payment decisions and how device developers and manufacturers prepare for and participate in these processes; and (2) to identify ways that private, voluntary action by the managed-care and medical-device industries might improve--for the benefit of society--these processes. The core data are from confidential interviews with eight companies that develop and manufacture medical devices and medical directors of nine MCOs. The findings should be of interest to medical-device developers and manufacturers, managed care organizations, public-policy makers, and researchers and analysts. A major impediment to socially appropriate adoption of emerging medical technologies is limited information about the performance of these technologies in day-to-day medical practice. The authors discuss prospects for improving four elements of information availability: --Developing better information before market introduction --Learning more from experience after market introduction --Evaluating and synthesizing clinical information --Disseminating information. They also discuss several other issues that warrant consideration: --Aligning private incentives of MCOs and payers with social values --Enhancing MCO capabilities to evaluate technologies and make decisions --Improving decisions by physicians --Reducing use of inappropriate or obsolete technologies --Reducing costs of decisionmaking for manufacturers and MCOs --Improving manufacturer understanding of the market environment --Helping MCOs and employers anticipate what is in the pipeline.

Offers health care professionals vital information about risks, benefits, and costs of new medical technologies to help them make informed decisions

This book aims to study the factors effecting the adoption and diffusion of Health Information Technology (HIT) innovation. It analyses the adoption processes of various tools and applications, particularly Electronic Health Records (EHR), highlighting the impact on various sectors of the healthcare system, such as physicians, administration and patient care, while also identifying the various pitfalls and gaps in the literature. With the various challenges currently facing the United States healthcare system, the study, adoption and diffusion of healthcare technology innovation, particularly HIT, is imperative to achieving national goals. This book is organized into three sections. Section one reviews theories and applications for the diffusion of Health Care Technologies. Section two evaluates EHR technology, including the barriers and enables in adoption and alternative technologies. Finally, section three examines the factors impacting the adoption of EHR systems. This book will be a key source for students, academics, researchers, practitioners, professionals and policy-makers.

Chapter 1. New health technologies: Managing access, value and sustainability Chapter 2. The past and potential future impact of new health technology Chapter 3. Innovation, access and value in pharmaceuticals Chapter 4. Ensuring timely and affordable access to medical devices Chapter 5. Achieving the promise of precision medicine Chapter 6. Digital technology: Making better use of health data

The use of technology in health sciences has a direct impact on health outcomes, as well as on the quality and the safety of healthcare processes. In addition, the use of new technological developments in medical education has proven to be greatly effective and creates realistic learning environments to experience procedures and devices that will become common in medical practice. However, bringing new technologies into the health sector is a complex task, which is why a comprehensive vision of the health sciences ecosystem (encompassing many different areas of research) is vital. Technological Adoption and Trends in Health Sciences Teaching, Learning, and Practice obtains an overview of the technological trends within the health sciences ecosystem, identifies the strengths and weaknesses of the research presented to date, and depicts possible future research directions within health science education and practice. Covering topics such as artificial intelligence and online laboratories, it is ideal for health sciences educators and practitioners, technological solution providers, health organizations, health and care workers, regulators, governing bodies, researchers, academicians, and students.

New medical technologies pharmaceuticals, medical devices, and procedures often allow great improvements in the outcomes of medical care, but they are also widely believed to be a major cause of increasing costs. Selective adoption of new technologies, the taking on of only those technologies for which the medical benefits exceed the costs to society of developing and using them, is a crucial element in the quest to control health care costs while preserving or enhancing the quality of care. This report focuses on adoption of innovative medical technologies by managed care organizations (MCOs). The project had two primary objectives: (1) to understand current processes MCOs use for making coverage, medical-necessity, and payment decisions involving emerging medical technologies, and how device developers and manufacturers prepare for and participate in these processes; and (2) to identify ways that private, voluntary action by the managed-care and medical-device industries individually or jointly might improve for the benefit of society the processes by which new medical technologies are developed, evaluated, and adopted or rejected for coverage.